Zurivogli 0.2mg Tablet
Marketer
Zurinovo Healthcare Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Zurivogli 0.2mg Tablet
Glycemia control tablets (0.2mg Zurivogli) are indicated for managing type 2 diabetes. This medication assists in postprandial blood glucose regulation, employed when dietary modifications and other comparable therapies prove insufficient. Administer Zurivogli 0.2mg immediately prior to meals; dosage and frequency are determined by your physician to optimize glycemic control. Discontinuation requires medical consultation; abrupt cessation may elevate blood glucose, potentially causing severe complications such as nephropathy or vision impairment. This medication complements a comprehensive treatment strategy encompassing diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported adverse effects include abdominal discomfort, flatulence, appetite suppression, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While Zurivogli 0.2mg itself doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with pure glucose; sucrose is ineffective. Inform your physician of any hepatic or renal dysfunction prior to commencing treatment. Contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical counsel before use. Disclose all concomitant medications to ensure safety. Limit alcohol consumption to minimize the hypoglycemic risk.
Primary Ingredients of Zurivogli 0.2mg Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Zurivogli 0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Zurivogli 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Zurivogli tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Zurivogli 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Zurivogli 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 0.2mg Zurivogli tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Zurivogli 0.2mg Tablet works:
Zurivogli 0.2mg tablets are used to manage diabetes. Their mechanism of action involves suppressing intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Zurivogli 0.2mg Tablet ingestion is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Zurivogli 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Zurivogli 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Zurivogli 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use 0.2mg Zurivogli tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Zurivogli 0.2mg tablets. Dosage modification of Zurivogli 0.2mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Zurivogli 0.2mg Tablet :
Omit any missed Zurivogli 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Zurivogli 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently